1. Home
  2. ATRA vs TIMB Comparison

ATRA vs TIMB Comparison

Compare ATRA & TIMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATRA
  • TIMB
  • Stock Information
  • Founded
  • ATRA 2012
  • TIMB 1998
  • Country
  • ATRA United States
  • TIMB Brazil
  • Employees
  • ATRA N/A
  • TIMB N/A
  • Industry
  • ATRA Biotechnology: Biological Products (No Diagnostic Substances)
  • TIMB Telecommunications Equipment
  • Sector
  • ATRA Health Care
  • TIMB Telecommunications
  • Exchange
  • ATRA Nasdaq
  • TIMB Nasdaq
  • Market Cap
  • ATRA 97.0M
  • TIMB 94.1M
  • IPO Year
  • ATRA 2014
  • TIMB 1998
  • Fundamental
  • Price
  • ATRA $14.41
  • TIMB $22.10
  • Analyst Decision
  • ATRA Strong Buy
  • TIMB Hold
  • Analyst Count
  • ATRA 3
  • TIMB 4
  • Target Price
  • ATRA $21.00
  • TIMB $20.17
  • AVG Volume (30 Days)
  • ATRA 52.1K
  • TIMB 307.6K
  • Earning Date
  • ATRA 11-11-2025
  • TIMB 11-04-2025
  • Dividend Yield
  • ATRA N/A
  • TIMB 6.32%
  • EPS Growth
  • ATRA N/A
  • TIMB 16.41
  • EPS
  • ATRA 0.56
  • TIMB 0.27
  • Revenue
  • ATRA $188,667,000.00
  • TIMB $4,779,664,328.00
  • Revenue This Year
  • ATRA N/A
  • TIMB $8.13
  • Revenue Next Year
  • ATRA N/A
  • TIMB $5.28
  • P/E Ratio
  • ATRA $25.58
  • TIMB $15.95
  • Revenue Growth
  • ATRA 202.41
  • TIMB 5.32
  • 52 Week Low
  • ATRA $5.01
  • TIMB $11.32
  • 52 Week High
  • ATRA $18.71
  • TIMB $22.47
  • Technical
  • Relative Strength Index (RSI)
  • ATRA 68.37
  • TIMB 60.63
  • Support Level
  • ATRA $13.12
  • TIMB $21.27
  • Resistance Level
  • ATRA $14.78
  • TIMB $22.47
  • Average True Range (ATR)
  • ATRA 0.84
  • TIMB 0.29
  • MACD
  • ATRA 0.16
  • TIMB 0.00
  • Stochastic Oscillator
  • ATRA 86.14
  • TIMB 69.17

About ATRA Atara Biotherapeutics Inc.

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).

About TIMB TIM S.A. (Each representing 5)

TIM, which is 67%-owned by Telecom Italia, is the third largest wireless carrier in Brazil, with 62 million subscribers, equal to about 24% of the market. The firm also owns 49% of I-Systems, an infrastructure partnership that is expanding its network footprint across Brazil. I-Systems can provide broadband service to about 9 million locations, equal to 10%-15% of the country. TIM leases capacity on the venture's network to serve retail broadband customers under the UltraFibra brand. TIM also resells fiber network access from other providers, including Oi's former infrastructure business V.tal. In total, TIM claims it can offer fixed broadband service to about 16 million locations.

Share on Social Networks: